Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:253Q77.7
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Spondyloepiphyseal dysplasia (SED) and spondyloepimetaphyseal dysplasia (SEMD) are a heterogeneous group of inherited skeletal disorders (osteochondrodysplasias) characterized by abnormal development of the spine (spondylo-), the ends of long bones (epiphyseal), and in the case of SEMD, also the growing portions of long bones (metaphyseal). These conditions primarily affect the skeletal system, leading to disproportionate short stature with a short trunk, abnormalities of the vertebral bodies (platyspondyly), and variable involvement of the limbs. The group encompasses multiple distinct subtypes, including spondyloepiphyseal dysplasia congenita (SEDc, caused by COL2A1 mutations), spondyloepiphyseal dysplasia tarda (SEDT, often X-linked due to TRAPPC2 mutations), and numerous forms of SEMD with varying genetic causes. Clinical features vary by subtype but commonly include short stature, barrel chest, kyphoscoliosis, lumbar lordosis, coxa vara, genu valgum, and joint pain or stiffness. Many patients develop early-onset osteoarthritis. Ocular complications such as myopia and retinal detachment can occur in COL2A1-related forms. Odontoid hypoplasia with cervical instability is a potentially serious complication in some subtypes, particularly SEDc, and may lead to spinal cord compression. Some forms are associated with hearing loss or cleft palate. There is currently no cure for SED or SEMD. Treatment is supportive and multidisciplinary, involving orthopedic management of skeletal deformities (including surgical correction of scoliosis, hip replacement, or cervical spine stabilization when needed), ophthalmologic monitoring, pain management, and physical therapy. Regular surveillance for cervical spine instability is critical in certain subtypes. Genetic counseling is recommended for affected families, as the inheritance pattern and prognosis vary significantly depending on the specific subtype and underlying genetic cause.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia.

View clinical trials →

No actively recruiting trials found for Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia community →

No specialists are currently listed for Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasiaForum →

No community posts yet. Be the first to share your experience with Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia.

Start the conversation →

Latest news about Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia

No recent news articles for Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia

What is Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia?

Spondyloepiphyseal dysplasia (SED) and spondyloepimetaphyseal dysplasia (SEMD) are a heterogeneous group of inherited skeletal disorders (osteochondrodysplasias) characterized by abnormal development of the spine (spondylo-), the ends of long bones (epiphyseal), and in the case of SEMD, also the growing portions of long bones (metaphyseal). These conditions primarily affect the skeletal system, leading to disproportionate short stature with a short trunk, abnormalities of the vertebral bodies (platyspondyly), and variable involvement of the limbs. The group encompasses multiple distinct subtyp